Pesticide exposure linked to higher risk of ALS, research finds

A sweeping systematic review published in Occupational and Environmental Medicine has brought renewed urgency to the conversation surrounding workplace chemical safety. Researchers evaluated data spanning from 1990 to 2025, narrowing their focus down to eleven peer-reviewed studies that examined occupational pesticide contact. When pooling the results, the analysis uncovered a striking correlation: individuals who encountered agricultural and industrial chemicals through their jobs faced an approximate 60 percent greater risk of developing amyotrophic lateral sclerosis, commonly known as ALS, compared to unexposed populations.

The findings point toward a worrying dose-response relationship, indicating that the probability of contracting the fatal neurodegenerative condition scales alongside the intensity of exposure. When researchers categorized the chemical agents, herbicides emerged with the steepest correlation, showing a 70 percent increase in ALS risk. These disparities emphasize that different chemical classes carry distinct biological properties, though the overarching pattern suggests that repeated, low-level contact over many years contributes heavily to long-term neurological damage.

This fresh evaluation arrives amid broader legal and regulatory battles over neurotoxic agents like the organophosphate chlorpyrifos. Widely used since the 1960s in agricultural settings, residential pest control, and military encampments during the Gulf War, chlorpyrifos has faced intense scrutiny. Recent scientific literature links the insecticide to oxidative stress, mitochondrial dysfunction, and the destruction of dopamine-producing brain cells, with separate studies noting that long-term residential proximity can more than double Parkinson’s disease risks. Despite historical attempts by federal regulators to restrict its use, legal challenges have repeatedly reinstated applications, leaving farmworkers, pesticide applicators, and nearby residents to bear the brunt of ongoing neurological risks.

Ultimately, while these meta-analyses and case-control studies successfully establish strong statistical associations and dose-response patterns, they cannot definitively prove direct causation on their own. The sheer complexity of chemical mixtures and individual workplace histories makes definitive tracking difficult. Nevertheless, the mounting evidence shifts the burden of proof heavily onto manufacturers and regulators. As global rates of neurodegenerative disorders continue to climb, the imperative to isolate hazardous compounds and protect vulnerable workers has never been more urgent.